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Abstract 
 
Apoptosis, a major form of programmed cell death, is an important mechanism to remove 
extra or unwanted cells during development. In tissue homeostasis apoptosis also acts as a 
monitoring machinery to eliminate damaged cells in response to environmental stresses. 
During these processes, caspases, a group of proteases, have been well defined as key drivers 
of cell death. However, a wealth of evidence is emerging which supports the existence of 
many other non-apoptotic functions of these caspases, which are essential not only in proper 
organism development but also in tissue homeostasis and post-injury recovery. In particular, 
apoptotic caspases in stress-induced dying cells can activate mitogenic signals leading to 
proliferation of neighboring cells, a phenomenon termed apoptosis-induced proliferation. 
Apparently, such non-apoptotic functions of caspases need to be controlled and restrained in 
a context-dependent manner during development to prevent their detrimental effects. 
Intriguingly, accumulating studies suggest that cancer cells are able to utilise these functions 
of caspases to their advantage to enable their survival, proliferation and metastasis in order to 
grow and progress. This book chapter will review non-apoptotic functions of the caspases in 
development and tissue homeostasis with focus on how these cellular processes can be 
hijacked by cancer cells and contribute to tumorigenesis. 
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1 Introduction 
 
Apoptosis was first identified as a form of cell death by its distinct morphological 
characteristics including cellular shrinkage, chromosome condensation, nuclear 
fragmentation and formation of apoptotic bodies (Kerr et al., 1972, Jacobson et al., 1997). 
Studies in C. elegans then uncovered that apoptosis is genetically controlled and plays critical 
roles during development to remove unwanted or unnecessary cells (Ellis and Horvitz, 1986, 
Ellis et al., 1991). Such function of apoptosis further extends to maintenance of tissue 
homeostasis by eliminating damaged or unfit cells (Thompson, 1995, Miura, 2011). 
Apoptosis has therefore been viewed as a monitoring program to identify and kill potentially 
harmful cells that may develop into cancer. Consistent with this idea, evading apoptosis has 
been considered as a hallmark of cancer (Hanahan and Weinberg, 2000, Hanahan and 
Weinberg, 2011). 
 
The key components of the apoptotic machinery are caspases, a family of cysteine proteases 
which cleave their substrates leading to cell death (Thornberry and Lazebnik, 1998, 
Hengartner, 2000). Recently however, in addition to their functions in apoptosis, caspases are 
becoming better understood in their multifunctional nature with an increasing number of non-
apoptotic functions discovered. We acknowledge the abundance of high quality reviews 
which have described with clarity the non-apoptotic functions of caspases in the context of 
development and tissue regeneration (Kuranaga, 2011, Miura, 2012, Connolly et al., 2014, 
Shalini et al., 2015). This chapter therefore focuses on the roles of caspases in sustaining 
cancers and promoting their spread which seems to contradict what we know about their roles 
in apoptosis. There is now certainly a great wealth of evidence to show that the apoptotic 
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caspases actually have multiple functions other than executing cell death, and cancer cells can 
hijack these activities to directly promote their growth, metastasis and recurrence after 
therapy. Here we have synthesised the evidence present in the current literature supporting 
this claim, to highlight that the caspases do indeed have a role in progressing cancers. Issues 
that may exist in current cancer therapies for particular patient subsets are also discussed.  
 
2 The apoptotic machinery: functions of the apoptotic caspases 
 
Apoptosis is an evolutionarily conserved mechanism in multicellular organisms, allowing 
correct pattern formation during development and the removal of cells which are detrimental 
to the health and survival of the organism (Degterev and Yuan, 2008, Fuchs and Steller, 2011, 
Green et al., 2014, Yamaguchi and Miura, 2015). The pathways leading to apoptosis have 
been elucidated in many organisms, including C. elegans, Drosophila and mammals, which 
are summarised in figure 1. A noticeable family of key components in these apoptosis 
pathways are the caspases. By definition, caspases are cysteine-aspartic acid proteases. They 
cleave their substrates after the aspartic acid residue which features at the end of short 
tetrapeptide motifs (Earnshaw et al., 1999, Hengartner, 2000). In addition to their functions in 
apoptosis, caspases are also well known for their roles in inflammatory responses (Lamkanfi 
et al., 2007, Lamkanfi and Dixit, 2014, Vanaja et al., 2015). For examples, there are 18 
known mammalian caspases among which caspase-2, -3, -6, -7, -8, -9 and -10 function in 
apoptosis and thus have been classified as apoptotic caspases (Eckhart et al., 2008, Shalini et 
al., 2015). This review focuses on these caspases especially the caspases-3, -7, -8 and -9 due 
to their multiple non-apoptotic functions reported.  
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Under normal cellular conditions all apoptotic caspases are present as inactive pro-caspases, 
called zymogens, which consist of a prodomain, a small subunit and a large subunit 
(Degterev et al., 2003, Earnshaw et al., 1999). They require cleavage in apoptotic cellular 
conditions to become activated. Based on the structure of N-terminal prodomains, apoptotic 
caspases can be subdivided into the initiator (or apical) and effector (or executioner) caspases. 
The initiator caspases have elongated prodomains which contain either the death effector 
domains (DED, e.g. for caspase 8) or the caspase-recruitment domains (CARD, e.g. for 
caspase 9). In contrast, the effector caspases have small prodomains. These caspases also 
have distinct functions and substrates during the process of apoptosis (Kumar, 2007, 
Chowdhury et al., 2008, Yan and Shi, 2005). The initiator caspases cleave inactive pro-
effector caspases and activate them. They are therefore also called apical caspases. In contrast, 
effector caspases, once activated by the initiator caspases, further cleave their broad range of 
cellular proteins leading to execution of cell death. They therefore have another name as 
executioner caspases. For simplicity, terms of initiator and effector caspases are used in this 
review. 
 
2.1 Apoptosis in C. elegans 
The caspases were first identified in C. elegans in which 131 cells undergo apoptosis during 
development by the action of a simple and linear pathway (Fig.1A) (Ellis and Horvitz, 1986, 
Ellis et al., 1991, Fuchs and Steller, 2011). Before an apoptotic stimulus is detected by a cell, 
CED-4, a homolog of the mammalian adaptor protein apoptosis activating factor 1 (Apaf-1), 
exists as a dimer, which is sequestered on the outer leaflet of the outer membrane of the 
mitochondria by contact with a Bcl-2 family member called CED-9 (Lettre and Hengartner, 
2006). Upon apoptotic stimulus, Egl-1, a pro-apoptotic BH3-only protein (Bcl-2 homology 3), 
is expressed, binding CED-9, thus releasing CED-4. Ced-4 is then free to form a tetramer. 
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Once the CED-4 tetramer is assembled, it can cleave and activate the caspase CED-3, which 
in turn activates other downstream apoptotic effector proteins leading to cell death (Fig.1A) 
(Conradt and Xue, 2005, Lettre and Hengartner, 2006).  
 
2.2 The intrinsic apoptosis pathway in Drosophila and mammals 
Unlike the linear pathway in C. elegans, apoptotic pathways of extrinsic and intrinsic origin 
have been identified in both Drosophila and mammals (Fig.1). The intrinsic pathway has 
been extensively studied in Drosophila (Fig.1B). Initially, apoptotic stimuli cause the 
expression of the pro-apoptotic genes of the RHG family: mainly reaper, hid (head involution 
defective) and grim (Kornbluth and White, 2005, Steller, 2008). These gene products act to 
relieve the repression exerted by the inhibitors of apoptosis (IAPs) (Wang et al., 1999, Lisi et 
al., 2000, Goyal et al., 2000), which, under normal cellular conditions, inhibits activities of 
the Drosophila initiator caspases such as Dronc (Meier et al., 2000, Wilson et al., 2002) and 
effector caspases such as DrICE and Dcp-1 (Hawkins et al., 1999, Yan et al., 2004). The 
major IAP in Drosophila is Diap1 whose function as an E3-ubiquitin ligase. Under no 
apoptotic stimuli, it binds to Dronc via its own BIR2 domain and causes ubiquitin to be 
tagged to Dronc (Wilson et al., 2002). Such ubiquitylation was believed to stimulate 
degradation of Dronc via the proteasome. However, a recent genetic analysis suggests that 
Diap1-mediated ubiquitylation blocks processing and activation of Dronc but does not lead to 
its protein degradation (Lee et al., 2011). When RHG proteins antagonise Diap1 by 
competitively binding to its BIR domains, Diap1 can no longer perform its function on 
inhibiting Dronc (Wilson et al., 2002, Ryoo et al., 2002, Yoo et al., 2002). From here released 
Dronc, although inactive, can induce formation of the apoptosome by the adapter protein Ark 
(Chai and Shi, 2014, Pang et al., 2015). Upon such interaction Dronc can autocleave and 
become activated. Activated Dronc further cleaves and activates its downstream effector 
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caspases, mainly DrICE and Dcp-1, leading to apoptosis (Fig.1B) (Hawkins et al., 2000, 
Dorstyn and Kumar, 2008, Snipas et al., 2008). Notably, pro-apoptotic proteins need to 
localize to the mitochondria and execute their apoptotic functions in Drosophila (Abdelwahid 
et al., 2007, Claveria et al., 1998, Claveria et al., 2002, Freel et al., 2008, Haining et al., 1999, 
Olson et al., 2003, Thomenius et al., 2011, Morishita et al., 2013). Two Bcl-2 family 
members, Debcl and Buffy, have been identified in Drosophila (Brachmann et al., 2000, 
Colussi et al., 2000, Igaki et al., 2000, Zhang et al., 2000, Quinn et al., 2003). Debcl is 
localized to the mitochondria and has pro-apoptotic functions, while Buffy may localize to 
endoplasmic reticula to carry out its own anti-apoptotic roles (Doumanis et al., 2007). 
 
In the mammalian intrinsic pathway, the mitochondrion plays a central and more decidedly 
important role (Fig.1C). The Bcl-2 family proteins can be subdivided into three groups: the 
BH3-only proteins (such as Bid, Bad, Bik, Bim, Noxa and Puma), the pro-apoptotic Bax 
subfamily members (such as Bax, Bak and Bok) and the anti-apoptotic Bcl-2 family members 
(such as Bcl-2 and Bcl-XL) (Vander Heiden et al., 1997, Yang et al., 1997, Gabriel et al., 
2003, Xiong et al., 2014). In response to apoptosis, BH3-only proteins either activate the Bax 
subfamily members or antagonize the anti-apoptotic Bcl-2 members to regulate mitochondrial 
outer membrane permeabilisation (MOMP) which then leads to release of cytochrome c (cyt 
c). Released cyt c binds to the adaptor protein Apaf-1, via the WD repeat domain at the 
carboxyterminus of Apaf-1, forming the apoptosome. Pro-caspase-9 can in turn interact with 
Apaf-1 in the apoptosome, via their mutual CARD domains (Srinivasula et al., 1998). Pro-
caspase-9 then autocleaves and becomes active (Kumar and Colussi, 1999). The activated 
caspase-9 further cleaves its downstream effector caspases, caspase-3 and -7, to trigger 
apoptotic cell death (Xiong et al., 2014). In addition to cyt c, pro-apoptotic proteins such as 
Smac (or Diablo) and HtrA2 (or Omi) are also released from mitochondria during the process 
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of MOMP (Silke et al., 2000, Suzuki et al., 2001, Green and Kroemer, 2004). Similar to what 
happens in Drosophila, these pro-apoptotic proteins antagonize IAPs such as XIAP leading to 
activation of caspase-9, -3 and -7 and apoptosis. In addition to Smac and HtrA2, another 
mammalian IAP antagonist is ARTS which is not released from mitochondria (Larisch et al., 
2000, Gottfried et al., 2004). Similar as the RHG proteins in Drosophila, it is localized to the 
mitochondrial outer membrane and inhibits XIAP (Edison et al., 2012).  
 
2.3 The extrinsic apoptosis pathway in Drosophila and mammals 
In contrast to the intrinsic pathway, the extrinsic pathway is initiated by the binding of a 
death ligand to a death receptor in the cell (Fig.1C). In mammals, examples of the death 
ligands are tumor necrosis factor (TNF) family members including Fas ligand (FasL) and 
TNF-related apoptosis-inducing ligand (TRAIL) (Ashkenazi and Dixit, 1998, Peter and 
Krammer, 1998, Lavrik et al., 2005). These ligands bind to their specific receptors Fas and 
DR4/5, forming complexes. Once such a ligand-receptor complex is formed, the adaptor 
protein Fas-associated Death Domain (FADD) can bind the cytosolic region of Fas and 
DR4/5. There, FADD acts as a platform on to which procaspase-8 can bind, by interaction of 
the death effector domain (DED) of FADD with the DED at the extended N-terminus of pro-
caspase-8, forming the death-inducing signaling complex (DISC) (Medema et al., 1997, Juo 
et al., 1998, Varfolomeev et al., 1998). Due to receptor clustering in the plasma membrane, 
the pro-caspase-8 monomers are brought within close proximity of each other in DISC 
complexes, and once in this newly established close proximity they can autocleave and 
become activated (Chang et al., 2003, Guicciardi and Gores, 2009). Upon activation, caspase-
8 can then cause the cleavage and activation of effector caspases caspase-3 and -7 leading to 
cell death (Hengartner, 2000, Chowdhury et al., 2008). Homologs of death ligands, receptors 
and their functions in apoptosis induction have also been found in Drosophila (Fig.1B). 
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There is only one TNF homolog, Eiger (Egr), identified in Drosophila so far (Moreno et al., 
2002, Igaki et al., 2002). Two TNF receptors including Wengen (Wgn) and, more recently, 
Grindelwald (Grnd) have been reported (Kanda et al., 2002, Andersen et al., 2015). 
Activation of Egr triggers both apoptosis and a type of non-apoptotic cell death through the 
Jun N-terminal Kinase (JNK) pathway, a stress-response signaling pathway (Moreno et al., 
2002, Igaki et al., 2002, Kanda et al., 2011, Ma et al., 2012). For the aspect of apoptosis, JNK 
induces expression of pro-apoptotic genes and activation of the apoptotic machinery (Moreno 
et al., 2002, Ma et al., 2012). Interestingly, in stress-induced apoptosis, the initiator caspase 
Dronc can activate not only effector caspases DrICE and Dcp-1 but also JNK which then feed 
back to the apoptosis pathway to further amplify it (Shlevkov and Morata, 2012). Notably, 
although different in their nature of inducing apoptosis, connections between the extrinsic and 
intrinsic pathways also exist in mammals. Caspase-8 can act on the pro-apoptotic BH3-only 
proteins such as BID leading to activation of the intrinsic pathway which further ensures a 
robust apoptotic response (Tang et al., 2000, Anto et al., 2002, Kantari and Walczak, 2011).  
 
3 Apoptosis, development and non-apoptotic functions of caspases 
 
Apoptosis and development are interconnected. On the one hand, apoptotic caspases were 
originally identified as key players in the developmental program (Ellis and Horvitz, 1986). 
Their apoptotic functions are critical for removal of extra cells produced at the early stage of 
development and elimination of unwanted cells in tissue patterning and morphogenesis 
(Fuchs and Steller, 2011). A recent study on Apaf-1 knock-out mice suggests that apoptosis is 
required to remove Fgf8 morphogen-producing cells and terminate Fgf8 production at the 
correct developmental time, thus ensuring proper development of the forebrain (Nonomura et 
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al., 2013). Apoptotic cells can even actively drive epithelial folding during morphogenesis 
(Monier et al., 2015) and cell extrusion during tissue repair (Kuipers et al., 2014). These 
examples have certainly underlined the developmental role of apoptosis. On the other hand, it 
is also becoming clear that the developmental program can modulate cellular apoptotic 
responses. Many key components in the apoptosis pathway can be targeted by the 
developmental program to define distinct cellular susceptibilities to apoptosis. For example, 
in Drosophila 3
rd
 instar larvae, a pulse of hormone ecdysone increases the whole organismal 
sensitivity to apoptosis by upregulating the basal level of Ark, Dronc and DrICE (Kang and 
Bashirullah, 2014). Furthermore, in the developing Drosophila eye tissue, multiple 
mechanisms were employed to control cellular levels of IAPs as well as pro-apoptotic 
proteins (Fan and Bergmann, 2014, Hilgers et al., 2010). Similarly, in mouse embryos, 
primed stem cells are very sensitive to apoptosis due to their low levels of BIM regulated by 
microRNAs (Pernaute et al., 2014). Therefore, cellular apoptosis susceptibility can be 
modulated by developmental programs. However, the links between apoptotic caspases and 
development are far beyond death.  Increasing evidence is now demonstrating the actual, true 
multifunctional nature of the caspases with somewhat surprising and fascinating roles in 
diverse cellular processes. These functions include regulating immune responses, promoting 
cell proliferation, and regulating cell differentiation and fate specification which have been 
extensively reviewed elsewhere (Jacobson et al., 1997, Kuranaga and Miura, 2007, Lamkanfi 
et al., 2007, Chowdhury et al., 2008, Kuranaga, 2012, Miura, 2012, Connolly et al., 2014, 
Shalini et al., 2015). Here, we highlight some of these non-apoptotic functions, in particular 
roles of caspases in tissue homeostasis, in the context of cancer development. 
 
4 Caspases in tissue homeostasis: apoptosis-induced proliferation (AiP)   
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Organisms are constantly exposed to environmental stresses. Damaged cells are frequently 
removed by apoptosis. Meanwhile, new cells are generated by proliferation to compensate for 
the cell loss thus to maintain tissue homeostasis. For example, up to 60% of cells in the 
developing Drosophila wing epithelial tissue can be lost in response to radiation without 
affecting final adult wing size and morphology (Haynie and Bryant, 1977). A similar 
phenomenon has also been found in the processes of wound healing and liver regeneration in 
mammals (Li et al., 2010c). Apparently, tissue homeostasis is important for tissue function to 
remain optimal and critical to organism survival. Evidence in multiple organisms including 
Hydra (Chera et al., 2009), Drosophila (Huh et al., 2004, Kondo et al., 2006, Fan and 
Bergmann, 2008b) and mouse (Li et al., 2010c)  is now demonstrating that apoptotic caspases 
have non-apoptotic functions to trigger compensatory proliferation, a process therefore 
termed apoptosis-induced proliferation (AiP) or apoptosis-induced compensatory cell 
proliferation (Fan and Bergmann, 2008a, Bergmann and Steller, 2010, Ryoo and Bergmann, 
2012, Mollereau et al., 2013). For simplicity we use the term apoptosis-induced proliferation 
(AiP) in this review. Recent studies in Drosophila provided mechanistic insights on how AiP 
occurs (Fig.2A,B) (Ryoo et al., 2004, Perez-Garijo et al., 2004, Huh et al., 2004, Wells et al., 
2006, Kondo et al., 2006, Fan and Bergmann, 2008b, Fan et al., 2014). Intriguingly, 
depending on the developmental state of the affected tissue, i.e. proliferating versus 
differentiating tissues, either initiator or effector caspases drive distinct mechanisms of AiP in 
Drosophila (Fan and Bergmann, 2008b).   
 
4.1 The initiator caspase-driven AiP in Drosophila   
The molecular mechanism of AiP was first addressed in Drosophila by taking advantage of 
caspase inhibitors (Ryoo et al., 2004, Perez-Garijo et al., 2004, Huh et al., 2004). P35, a 
baculovirus inhibitor of apoptosis, acts as a peudosubstrate of Drosophila effector caspases 
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e.g. DrICE and Dcp-1 (Hay et al., 1994). Expression of P35 thus blocks activity of DrICE 
and Dcp-1 and execution of cell death. To determine how stress-induced apoptotic cells may 
contribute to compensatory proliferation, such cells were kept “undead” by P35 (i.e. the 
apoptotic machinery is activated but execution of cell death is blocked). Surprisingly, 
“undead” cells stimulate overgrowth of surrounding tissues despite the presence of P35 
(Ryoo et al., 2004, Perez-Garijo et al., 2004, Huh et al., 2004). This suggests that dying cells 
release mitogenic signals to induce AiP independent of effector caspases. Further loss-of-
function analyses revealed that the initiator caspase Dronc, which is not inhibited by P35, 
actually coordinates apoptosis and AiP (Fig.2A). It appears that, at least in the “undead” 
model of AiP, Dronc activates JNK in dying cells leading to activation of several mitogenic 
signaling pathways including the Wingless (Wg, a homolog of the mammalian Wnt) and 
Decapentaplegic (Dpp, a TGF-β-like homolog of the mammalian BMP) signaling pathways 
which are required for AiP (Ryoo et al., 2004, Perez-Garijo et al., 2009). Drosophila 
homolog of p53 is also required for AiP, probably through its role in a feedback regulatory 
loop including JNK, p53 and pro-apoptotic genes (Shlevkov and Morata, 2012, Wells et al., 
2006). However, one concern of the “undead” model of AiP is that it may not represent what 
happens in the physiological process of AiP (Perez-Garijo et al., 2009, Martin et al., 2009, 
Bergantinos et al., 2010). For example, it has been suggested that Wg and Dpp are not 
required for AiP when there are no “undead” cells (Perez-Garijo et al., 2009). Nevertheless, a 
Drosophila model of regenerative growth without using P35 has identified Wg as an 
important factor which is induced in response to tissue damage and is required for tissue 
regeneration (Smith-Bolton et al., 2009). In addition to these, a recent genetic screen using 
both an “undead” model and a P35-independent regenerative model has discovered a role of 
EGFR signaling in AiP and tissue regenerative growth (Fan et al., 2014). In this process, JNK 
transcriptionally induces Spi, one of EGF ligands in Drosophila, in dying cells which then 
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activates proliferation of neighboring cells via EGFR signaling. JNK can also activate the 
transcription factor Yorkie (Yki) in the Hippo signaling pathway to regulate AiP in 
developing Drosophila wing tissues (Sun and Irvine, 2011, Sun and Irvine, 2013). 
Interestingly, such a role of Yki in AiP seems to be tissue-specific as it is not required for AiP 
in proliferating eye tissues (Fan et al., 2014). 
 
4.2 The effector caspase-driven AiP in Drosophila   
A second form of AiP was identified in the differentiating Drosophila eye tissue which is a 
monolayer epithelium with differentiated photoreceptor cells at the apical side and cell-cycle-
exited but unspecified cells at the basal side (Fan and Bergmann, 2008b).  At the late 3
rd
 
instar larval stage, both types of cells have relatively low susceptibility to apoptosis 
presumably due to their post-mitotic status and protection of survival signals such as high 
Diap1 and the EGFR signaling (Fan and Bergmann, 2014). Therefore under apoptotic stresses, 
e.g. expression of the pro-apoptotic gene hid, these cells do not die immediately. Instead, the 
stressed photoreceptor neurons release Hedgehog (Hh), another evolutionarily conserved 
growth signaling ligand, to trigger cell cycle re-entry of unspecified cells (Fig.2B). Such an 
AiP event can be blocked by P35 or double mutants of DrICE and Dcp-1 suggesting an 
effector caspase-driven form of AiP is employed in the differentiating eye tissue (Fan and 
Bergmann, 2008b). Interestingly, mechanisms of AiP seem to be operated in a context-
dependent manner. This is best shown in the developing Drosophila eye tissue. The late 3
rd
 
larval eye tissue consists of an anterior proliferating portion where all cells are actively 
dividing and a posterior differentiating portion where most of the cells present have exited the 
cell cycle. The initiator caspase-driven AiP appears to be employed in proliferating tissues, 
while the effector caspase-driven AiP is employed in differentiating tissues (Fan and 
Bergmann, 2008b). However, what controls such distinction is not yet known. 
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4.3 AiP in other organisms including mammals   
In addition to Drosophila, roles of AiP in regeneration have also been implicated in other 
multi-cellular organisms particularly in Hydra, Xenopus and mouse (Chera et al., 2009, Tseng 
et al., 2007, Li et al., 2010c, Bergmann and Steller, 2010). In the freshwater Hydra, both head 
and foot can regenerate completely after bisection at the midgastric area. Massive localized 
apoptosis was observed for the head regenerating tip, but not the foot regenerating 
counterpart, preceding increase of cell proliferation (Chera et al., 2009). Interestingly, ectopic 
activation of apoptosis at the foot regenerating tip resulted in regeneration of head instead of 
foot. In this process, caspases activate Wnt3, a homolog of Drosophila Wg, in dying cells 
leading to regenerative proliferation (Chera et al., 2009). This study suggests that apoptosis 
can direct certain regenerative programs. Similar requirements of caspases in regeneration 
were also reported for Xenopus tadpole tail regeneration which is abolished by inhibiting 
caspase-3 (Tseng et al., 2007). Notably, in other regeneration models such as planaria and 
newt, massive apoptosis at the amputation site has been observed (Pellettieri et al., 2010, 
Pellettieri and Sanchez Alvarado, 2007, Vlaskalin et al., 2004). However, it is not yet clear 
whether apoptotic caspases actually drive release of mitogenic signals such as Wnt, TGF-β 
and Hh in these processes. More recently, roles of AiP in mammals were reported in mouse 
models of wound healing and liver regeneration (Li et al., 2010c, Jung et al., 2010). The rate 
of skin wound healing and liver regrowth after partial hepatectomy were significantly 
reduced in caspase-3 or -7 deficient mice due to impaired post-injury cell proliferation. It was 
further revealed that activated caspase-3 and -7 cleave calcium-independent phospholipase 
A2 (iPLA2) to increase its catalytic ability and promote synthesis of prostaglandin E2 
(PGE2). Release of PGE2 from the dying cell then induces compensatory proliferation 
(Fig.2C) (Li et al., 2010c). Although detailed mechanisms on how PGE2 triggers 
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compensatory proliferation are not yet revealed, the link between PGE2 and the Wnt 
signaling cascade have been established in both zebrafish and mice (Goessling et al., 2009). 
PGE2 binds to the EP2, a G-protein coupled receptor, leading to activation of β-catenin, a 
key intracellular transducer of Wnt signaling (Castellone et al., 2005, Moon et al., 2004, Jager 
and Fearnhead, 2012).  
 
5 Caspases in cancer development: non-apoptotic functions 
 
Current cancer therapies such as chemo- and radiotherapies frequently aim to activate 
apoptosis of cancer cells. Therefore activating apoptosis has long been viewed as an “anti-
cancer” process. However, increasing evidence is now suggesting that apoptotic caspases can 
play oncogenic roles through their non-apoptotic functions (Fig.3). Intriguingly, such “pro-
cancer” functions of caspases seem not to be an invention by cancer cells. As discussed above 
the roles of the apoptotic caspases are essential in proper organism development and tissue 
homeostasis. Apparently such multi-functional nature of caspases needs to be tightly 
controlled and restrained by cellular contexts in order to prevent their detrimental effects. In 
the context of cancer, these non-apoptotic functions of caspases can be hijacked to ensure 
survival of cancer cells and promote their spread. Thus, the multifunctional nature of the 
apoptotic caspases is becoming clinically important. 
 
5.1 Caspases promote cell survival and cell proliferation 
The crucial function of caspases in cell survival and proliferation has been reported during 
development. Targeted disruption of caspase-8 in mice causes embryonic lethality, a feature 
not shared by the other caspases (Varfolomeev et al., 1998, van Raam and Salvesen, 2012). 
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Caspase-8
-/-
 mouse embryos exhibited abnormal phenotypes prior to death, namely 
hyperemia, with the number of hematopoietic precursors significantly reduced (Varfolomeev 
et al., 1998). This suggests that caspase-8 is required for either maintenance or proliferation 
of hematopoietic precursors. As further supports for this view, depletion of caspase-8 in 
lymphoid tissues inhibits antigen-induced T and B lymphocyte proliferation (Salmena et al., 
2003, Beisner et al., 2005, Su et al., 2005). Although it was originally thought that caspase-8 
regulates cell proliferation in these cases, it is more likely that caspase-8 has pro-survival 
functions due to its inhibitory role on necroptosis, another form of programmed cell death 
(Oberst and Green, 2011, van Raam and Salvesen, 2012). The key factors involved in such 
regulation are caspase-8, the long isoform of cellular FLICE-like inhibitory protein (FLIPL), 
and two kinases, RIPK1 and RIPK3, which are required for activation of necroptosis. FLIPL 
is structurally similar to caspase-8 but without its catalytic activity (Zhou et al., 2004). It can 
bind to pro-caspase-8, forming a heterodimer which prevents caspase-8 from completing its 
apoptotic functions by occupying all binding sites of caspase-8 in the DISC. This 
consequently prevents caspase-8 homodimer formation. Therefore, when the FLIPL levels are 
low, homodimerization of pro-caspase-8 occurs which activates caspase-8 for its apoptotic 
function. In contrast when FLIPL levels are high, e.g. triggered by survival signals mediated 
by a transcription factor NFκB, formation of the pro-caspase-8-FLIPL heterodimer does not 
trigger apoptosis. Instead, it can bind to the RIPK1-containing complex to suppress its 
activation on RIPK3 and necrotic cell death, although the underlying mechanism remains 
unclear (Oberst and Green, 2011). Hence, the level of FLIPL is crucial for caspase-8-
regulated cell survival. Interestingly, an increase in FLIPL expression has been detected in a 
variety of tumor types, including B-cell chronic lymphocytic leukaemia, pancreatic cancer 
and ovarian cancer, amongst many others (Ghavami et al., 2009, Ili et al., 2013). Down-
regulating FLIPL levels in tumors sensitises the cells to apoptosis (Ghavami et al., 2009, 
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Sharp et al., 2005). This is most likely due to decreased ability for caspase-8-FLIPL 
heterodimers to form and increased ability of caspase-8 homodimerization, which can then 
activate caspase-3 and apoptosis. In a study of cervical cancers, high grade tumors were 
found to have higher expression of FLIPL (Ili et al., 2013). Moreover, increasing grade of 
lesions was directly associated to increased c-FLIP expression, where 12.5% of normal 
cervical epithelia stained positive for relevant expression of FLIPL compared to 82.1% of 
squamous cervical carcinomas stained positive for FLIPL (Ili et al., 2013). This shows the 
significance in correlation of uncontrolled caspase-8-FLIPL dimer formation and cancer 
progression. Interestingly, infection by high-risk human papillomavirus (HPV), particularly 
HPV-16, was highly significantly correlated with high expression of FLIPL (Wang et al., 
2007). Although the viral infection does not explain the cause of high FLIPL expression in 
other cancer types, high expression of FLIPL was determined to be a marker of early cervical 
carcinogenesis and therefore has the potential to be utilised for early diagnosis (Ili et al., 2013, 
Wang et al., 2007). This evidence highlights that the caspase-8-FLIPL heterodimer can be 
hijacked by cancer cells to promote tumor survival, by avoiding the apoptotic functions of 
caspase-8. 
 
In addition to the initiator caspases, the effector caspases have also been implicated in 
promoting cell survival and cell cycle progression. In cultured cancer cell lines with the 
origin of leukemia or hepatocellular or cervical carcinoma, caspase-3 and -7 are found to be 
required in cell cycle progression through the G1 and G2/M checkpoints (Hashimoto et al., 
2011, Hashimoto et al., 2008). Overexpression of the BIR2 domain of XIAP inhibits caspase-
3 and -7, and when added to cells also induced cell cycle arrest. In contrast, inhibition of 
caspase-9 by expression of the BIR3 domain of XIAP did not cause the same effect, which 
indicates that caspase-3 and -7 have functions independent of caspase-9 activity. Although it 
   18 
 
is not yet clear how caspase-3 and -7 may promote cell cycle without being cleaved by 
caspase-9, the anaphase-promoting complex/cyclosome (APC/C), which regulates 
degradation of various cell cycle regulators through ubiquitylation, failed to form when 
caspase-3 and -7 were inhibited (Hashimoto et al., 2011). This suggests that pro-caspase-3 
and -7 may contribute to cell proliferation. Interestingly, direct substrates of caspases 
including cell cycle regulators can also promote cell survival or cell cycle progression at least 
in some circumstances. For example, the cyclin-dependent kinase inhibitor P27
Kip1
 can be 
cleaved by caspase-3 which then becomes activated and anti-apoptotic to protect human 
leukemic cells from death (Eymin et al., 1999). In addition to this, a more recent study 
suggested that caspase-3 can act as a sensor to extracellular stresses, therefore determining 
whether the cells live or not (Khalil et al., 2012). In this study, caspase-3-knockout mice 
become more sensitive to UV radiation with increased number of cells undergoing necrosis 
compared to the control animals. In response to doxorubicin, an anticancer drug inducing 
apoptosis of cardiomyocytes, the caspase-3 deficient mice also show significantly increased 
number of apoptotic cardiomyocytes which die through the caspase-7 instead (Khalil et al., 
2012). Caspase-3, but not caspase-6 and -7, cleaves the p120 RasGAP protein in vitro to 
activate a kinase Akt leading to survival functions of the PI3K signaling (Yang and Widmann, 
2002, Yang et al., 2004). Consistently, Akt activity, indicated by the level of phosphorylated 
Akt, increases in response to stresses such as UV radiation and doxorubicin injection. But 
such increase is strongly reduced in caspase-3-knockout mice. Knockin mice with a RasGAP 
mutant resistant to caspase-3 cleavage can restore their apoptotic sensitivity (Khalil et al., 
2012). Given these findings of caspases in cell survival and proliferation, could they 
contribute to tumorigenesis? As discussed below (see Sect. 5.3), the answer becomes clear by 
discovering roles of AiP in tumor reoccurrence following cytotoxic cancer therapies.   
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5.2 Caspases and metastasis 
Metastasis is a crucial process during cancer development as it is the cause of approximately 
90% of cancer related deaths (Hanahan and Weinberg, 2011). Yet it is an incredibly complex 
process consisting of multiple key steps for a cancer cell, or a group of cancer cells, to 
progress through (Geiger and Peeper, 2009).  These steps include breaking away from a bulk 
tumor, disseminating in the blood or lymph, exiting the circulation, then establishing and 
repopulating at a new site, where a secondary tumor forms. Interestingly, caspases have been 
implicated in aiding some of these steps through their non-apoptotic functions in cell 
migration, angiogenesis, and possibly cell dedifferentiation.  
 
Caspases have been reported for their functions in controlling cell motility during 
development. In Drosophila, Dronc, the caspase-9 homolog, is required for migration of 
border cells in the ovary (Geisbrecht and Montell, 2004), a process critical for oocyte 
development. In mammals, caspase-8
-/-
 mouse embryos die with a circulatory failure 
suggesting roles of caspase-8 in migration of endothelial cells (Varfolomeev et al., 1998, 
Kang et al., 2004). Similarly, in cancer specific studies, caspase-3 and its downstream targets 
have been implicated in causing tumor cell migration, thus contributing to achieving 
metastasis. Caspase-3 has been shown in ovarian cancer cells to be involved in the process of 
initiating cell migration, via activation of arachidonic acid, the precursor of PGE2 similarly 
as in the context of AiP described above (Fig. 2C) (Zhao et al., 2006, Jager and Fearnhead, 
2012, Portela and Richardson, 2013). Ovarian cancer cells have strong migratory responses 
towards laminin-10/11, a protein component of the extracellular matrix. This is probably due 
to the high levels of β1 integrin in ovarian cancer cells because binding of laminin-10/11 to 
β1 integrin leads to a moderate increase of caspase-3 activity (Zhao et al., 2006). Although 
the intermediate molecules determining caspase-3 activation from integrin-laminin binding 
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are unknown, Zhao et al. (2006) determined the moderate increase of caspase-3 activity does 
not lead to apoptosis, instead, it cleaves iPLA2 and activate its enzymatic activity to produce 
arachidonic acid and then PGE2. Consistently, pan caspase inhibitors, caspase-3-specific 
inhibitors or knockdown of iPLA2 inhibits migration of these cells. Interestingly, cleaved 
iPLA2 also activates the Akt survival signaling to protect these cells from apoptosis (Zhao et 
al., 2006). This further enhances cancer cell migration. Not surprisingly the arachidonic acid 
has also been implicated to be the driving factor of cell migration in other cancers including 
prostate cancers (Brown et al., 2014). Further support to roles of caspase-3 in cell migration 
comes from a study on lung cancer metastasis (Cheng et al., 2008). In this study, however, a 
protease-independent function of caspase-3 was suggested to promote metastasis. The authors 
used A549 cells, derived from high malignancy lung adenocarcinoma cells with high levels 
of caspase-3, for their study. Knockdown of caspase-3 in A549 cells diminishes their 
metastatic activities in the lungs when these cells were injected into the nude mice via tail 
vein suggesting roles of caspase-3 in promoting metastasis. Consistently, ectopic expression 
of caspase-3 in MCF-7 cells, derived from caspase-3-deficient and low malignancy breast 
cancer cells, enhances metastatic ability of these cells. Following these, the authors found that 
high levels of caspase-3 actually lead to high activity of the extracellular signal-regulated 
kinases (ERK) which are required for the observed lung metastasis. But intriguingly, such 
increased ERK activity and cell migration are not affected by the caspase inhibitor Z-DEVD-
FMK. Furthermore, expression of protease-dead mutants of caspase-3 in MCF-7 cells still 
enhances their migration through increased ERK activities. Although it is not yet clear, the 
acid sphingomyelinase and its downstream signal molecule ceramide were suggested to be 
the molecules linking caspase-3 and ERK (Cheng et al., 2008). Interestingly, another 
mechanism of caspase-3-dependent cell migration has been reported for the “undead” cells in 
Drosophila models (Rudrapatna et al., 2013). In this case, DrICE, a caspase-3 homolog in 
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Drosophila, activates JNK leading to cell migration and tissue invasion. Therefore, cellular 
contexts may determine how caspase-3 promotes cell motility.  
 
Following invasion and migration of cancer cells, angiogenesis is essential to further cancer 
progression, enabling tumor growth above a diameter of 1mm and metastasis (Geiger and 
Peeper, 2009). Knockdown of caspase-8 suppressed the vascular endothelial growth factor 
(VEGF)-mediated angiogenic signaling (Na et al., 2014). Interestingly, such requirement of 
caspase-8 in promoting angiogenesis is not affected by Ac-IETD-cho, a caspase-8 inhibitor 
that maintains high levels of pro-caspase-8. In contrast, the same study also showed that 
caspase-8 is required in TRAIL signaling to antagonize angiogenesis which can be inhibited 
by Ac-IETD-cho (Na et al., 2014).   Therefore, pro-caspase-8 and caspase-8 appear to have 
distinct functions during angiogenesis mediated by VEGF. 
 
Another cellular process that can potentially impact on cancer metastasis is cell 
dedifferentiation. Although it is still a subject of debate, existence of “cancer stem cells”, a 
small fraction of stem cell-like cancer progenitor cells, may facilitate or even establish the 
metastatic colonies for cancer progression (Geiger and Peeper, 2009). If this is true, 
maintenance and reprograming, thus dedifferentiation, of cancer cells may be crucial in the 
process of metastasis which, again, may involve caspases. Notably, both caspase-8 and 
caspase-3 are required for the dedifferentiation of murine fibroblasts to form induced 
pluripotent stem cells (iPSCs) in vitro (Li et al., 2010a). Activation of caspase-8 and -3 are 
induced by expression of Oct-4, one of the four transcription factors used to program iPSCs. 
By inhibiting caspase-8 the cells were completely unable to develop into iPSCs, whereas 
some could if only caspase-3 was inhibited suggesting potential roles of other effector 
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caspases such as caspase-7 in induction of iPSCs. The authors further showed that the 
caspases act upon retinoblastoma susceptibility protein (Rb), but how from here the 
phenotype of a pluripotent stem cell is produced is unknown although p53 and its 
downstream cell cycle regulator p21 have been implicated in the process (Li et al., 2010a). 
Interestingly, studies of human tumors in relation to their Oct-4 expression showed that 
tumors expressing high levels of Oct-4 resulted in increased metastases, shorter survival and 
furthered disease progression in comparison to tumors low in Oct-4 expression (Chang et al., 
2002). A recent study further sorted murine breast cancer 4T1 cells with either high or low 
Oct-4 expression and tested their tumorigenic potential in vivo by injecting sorted cells into 
the mouse mammary glands (Kim and Nam, 2011). The results support that Oct-4 can 
enhance cancer stem cell properties. This fits in vitro data and hypotheses theorising on the 
capacity of cancer stem cells in disease progression, though of course more studies are 
required in a greater range of tumor types. 
 
5.3 Caspases in tumor repopulation following cytotoxic cancer therapies 
Cytotoxic therapies exert their anti-tumor properties by inducing apoptosis as a result of 
DNA damage (Fulda and Debatin, 2006). As discussed above, AiP is a process utilised in 
non-cancerous tissue in order to maintain tissue homeostasis that allows tissue regeneration 
and recovery from damage. Consequently, this means that cytotoxic therapies can potentially 
induce not only cell death but also the AiP pathway which may in fact counteract cancer 
treatment. Tumors, to some extent, are comparable to standard developmental tissues (Dick, 
2008), and, conceivably, when damaged they can respond in the same way to regenerate and 
to compensate for the inflicted damage, thus to repopulate and reoccur. Recent studies on AiP 
in cancer models suggested this is the case. In one study, experiments were conducted to find 
out how caspase-3 is responsible for promoting accelerated tumor repopulation following 
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cytotoxic therapy in 4T1 murine breast cancer cells (Huang et al., 2011). It was found that the 
AiP pathway, activated in either cancer cells or stromal cells, could become hijacked by 
cancer cells following radiotherapy, causing accelerated tumor repopulation in vitro and in 
vivo, in nude mice. These were also confirmed with human breast cancer cell lines in the 
nude mice (Huang et al., 2011). The results gained in this study were further developed upon 
in studies on metastatic melanoma, showing that chemotherapy too can result in AiP and 
tumor repopulation (Donato et al., 2014). As in the tissue regeneration mouse model, it is 
PGE2 which is secreted from apoptotic cells and stimulates recipient living cells to proliferate 
in the tumor repopulation model (Fig.2C) (Donato et al., 2014, Huang et al., 2011). The 
authors also found that tumors with elevated caspase-3 were more resistant to radiotherapy 
than those with reduced caspase-3 (Huang et al., 2011). This at first seems paradoxical 
however with regards to the AiP model this observation seems to be logical. Higher caspase-
3 expression allows for greater production of PGE2, which in turn stimulates the increased 
growth rate of surviving cells, thus ensuring the maintenance of a larger tumor mass. Huang 
et al. found that the therapy sensitive cells were induced to undergo apoptosis, and the release 
of prostaglandins from the therapy sensitive cells caused the therapy resistant cells to 
proliferate at an accelerated rate and repopulate the treated tumor (Huang et al., 2011). 
 
Statistical studies have been conducted to give a measure of how higher expression of 
particular caspases in tumors can affect outcome and survival likelihood. In a study of breast 
cancer, 103 out of 137 tumors were deemed to have high levels of caspase-3, although some 
activity was noticed in all of the tumors (Nakopoulou et al., 2001). Increased caspase-3 level 
significantly correlated with worsened survival of the patients sampled and, in the tumors 
sampled, caspase-3 was only found in the cytoplasm, not the nucleus where the apoptotic 
target of caspase-3 resides. This suggests a possible mechanistic block preventing the effector 
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caspase-3 from reaching its target molecule, the inhibitor of caspase-activated DNase (iCAD), 
to free caspase-activated DNase (CAD) which can cause DNA fragmentation and subsequent 
cell death (Nakopoulou et al., 2001). Another study assessing implications of caspase-3 in 
gastric, ovarian, cervical and colorectal cancers concluded that patients possessing tumors 
which expressed higher caspase-3 had shortened survival time and also found that caspase-3 
expression was significantly associated with tumor stage (Hu et al., 2014). Both studies 
concluded that higher caspase-3 expression resulted in worsened prognosis. Notably, 
participants of these studies had not undergone any form of therapy. However, these findings 
of statistical significance were further confirmed by Huang et al. (2011), on patients who had 
undergone radiotherapy or chemotherapy.  
 
Given these new insights of mechanisms causing tumor repopulation following cytotoxic 
therapy, if repopulation is to be prohibited in tumors, then the AiP pathway needs to be 
blocked while still allowing caspase-3 to carry out its apoptotic functions. As described for 
AiP (Fig.2C), PGE2 is synthesised from arachidonic acid by cyclooxygenases (COX). Thus, 
COX inhibitors in theory should prevent the AiP pathway from progressing. This has been 
shown in practice, where administering a COX inhibitor in conjunction with cytotoxic 
therapy significantly decreases rate of tumor repopulation (Huang et al., 2011, Donato et al., 
2014). Therefore, use of a COX inhibitor in conjunction with the cytotoxic therapy may 
benefit patients possessing tumors with high levels of caspase-3. Notably, caspase-3 may not 
be the only components in the apoptosis pathway that can promote cancer tumorigenesis as 
suggested by studies on lymphoma (Michalak et al., 2010, Labi et al., 2010). Further 
mechanistic understanding of AiP in various cellular contexts will be the key to maximize its 
clinical benefits. Interestingly, in addition to AiP, engulfment of apoptotic cells by 
macrophages can create a tumor-promotive microenvironment by releasing signaling 
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molecules (Steidl et al., 2010, Qian et al., 2011, Willems et al., 2014) and regulating various 
aspects of tumor progression (Ford et al., 2015). Again, caspases play key roles here. 
Activation of iPLA2 by caspase-3 leads to production of lysophosphatidylcholine (LPC), as 
well as PGE2, from dying cells (Lauber et al., 2003). LPCs, together with several other 
molecules such as sphingosine-1-phosphates (S1Ps) and the nucleotides ATP and UTP, 
recruit macrophages to engulf apoptotic cells (Ravichandran, 2011). Therefore, apoptotic 
caspases can promote tumorigenesis directly through AiP or indirectly through recruiting 
macrophages (Jager and Fearnhead, 2012). This is further discussed in the Chapter 3.     
 
6 Concluding remarks  
 
For many years the apoptotic function of caspases has been considered, both in 
developmental settings and in a cancer setting, where activation of apoptotic proteins is 
considered to be essential in causing cell death and reducing tumor burden (Hanahan and 
Weinberg, 2011). While these considerations of caspase function remain valid, increasing 
evidence suggested that non-apoptotic functions of the apoptotic caspases exist in a context-
dependent manner. These functions are crucial in development and tissue homeostasis, where 
caspases have been implicated in stem cell pool maintenance by enhancing survival pathways 
and in AiP for tissue recovery upon cell loss, in which we have learned a lot from Drosophila 
models. Intriguingly, a wide range of non-apoptotic functions of caspases have been 
implicated in promoting tumor growth, metastasis and recurrence post-cytotoxic therapy 
(Fig.3). It is therefore worthwhile to consider not only how to kill the tumor cells, but also 
how to prevent tumour spread and repopulation. Further understanding of molecular 
mechanisms and cellular contexts leading to various non-apoptotic functions of caspases 
would certainly be beneficial.  
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